Central Venous Catheter-related Complications in Patients Under Anticancer Treatment

• Conditions: Central Venous Catheter Related Bloodstream Infection; Hematologic Malignancy; Central Venous Catheter Thrombosis; Solid Tumor

• Registration Number: NCT05455866
• Lead Sponsor: Centre Hospitalier Alpes Leman

Brief Summary

Oncology and hemotology patients under anticancer treatments are exposed to increased risks of central venous catheter-related complications due to the underlying cancer and its treament.

This prospective observational monocentric french study aims at describing the incidence of such complications, their morbimortality, and analyzing some risk factors in order to contribute to propose some strategies to reduce these complications' rate and consequences

Detailed Description

Not available

Study Timeline

• Status Verified: 2022-07
• Study First Submitted: 2022-07-08
• Study First Submitted QC: 2022-07-08
• Last Update Submitted: 2022-07-08
• Study Start: 2022-07-11
• Study First Posted: 2022-07-13
• Last Update Posted: 2022-07-13
• Primary Completion: 2023-01
• Study Completion: 2023-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

All patients older than 18 years, with solid cancer or hematological malignancy receiving anticancer treatment in the outpatient medical department of Alpes Leman Hospital and having a central venous catheter been placed between the 11th of July 2022, and the 1st of January 2023.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence rate and density of central venous catheter-related complications (infections, thromboses, extravasation)	6 months

Secondary Outcome Measures

Name	Time	Method
Incidence rate of severe central venous catheter-related complications	6 months